References
- Bernfeld P., Kelly T. F. Inhibitory and activating effects of polyanions on lipoprotein lipase. Journal of Biological Chemistry. 1963; 238: 1236–1241
- Dagostino L., Danielc B., Pignata S., Dargenio G., Mauacca G. Modification in erythrocyte diamine oxidase distribution induced by heparin in the rat. Biochemical Pharmacology 1989; 38: 4149
- Marklund S. L. Human coppercontaining superoxide dismutase of high molecular weight. Proceedings of the Nationol Acaakmy of Sciences USA. 1982; 19: 7634–7638
- Karlsson K., Marklund S. L. Plasma clearana of human extracellular-SOD C in rabbits. Journol of Clinical Investigotion. 1988; 82: 762–766
- Karlsson K., Marklund S. L. Extracellular superoxide dismutase in the vascular system of mammals. Biochemicol Journal 1988; 255: 223–228
- LeComte J., Hugues J. Action inhibitrice de l'héparine sur le phénomenc d'Arthus. International Archives of Allergy. 1954; 5: 367–373
- Lider O., Babrav E., Mekori Y. A., Miller T., Naparstek Y., Vlodavsky I., Cohcn I. R. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparin. Journal of Clinical Investigation. 1989; 83: 752–756
- Oyanagui Y. Reevaluation of assay method and establishment of kit for superoxide dismutasc. Analytical Biochemistry. 1984; 142: 290–296
- Oyanagui Y., Sato S. Heparin. a potent releasing agent of extracellular superoxide dismutase (EC-SOD C), suppressed ischemic paw edema in mice. Free Radical Research Communications. 1990, (in press).
- Oyanagui Y., Sato S., Okajima T. Suppression of ischemic paw oedema in mice. rats and guinea pigs by superoxide dismutases from different sources. Free Radical Research Communications. 1988; 4: 385–396
- Karlsson K., Lindahl V., Marklund S. L. Binding of human extracellular SOD C to sulphated glycosaminoglycan. Biochemistry Journal 1988; 256: 29–30
- Brestcl E. P., McClain E. J. A mechanism for inhibition of luminol-dependent neutrophil chcmiluminescence by polyanions. Journal of Immunology. 1983; 131: 2515–2519
- Halpern B., Milliez P., Lagrue G., Fray A., Morard J. C. Protective action of heparin in experimental immune nephritis. Nature 1965; 4968: 257–259
- Johansson S. A. Inhibition of thrornbocytopenia and 5-hydroxy-tryptarnine release in anaphyl-actic shock by heparin. Acta Physiologica Scandinavico. 1960; 50: 95–107
- Arieffand A. I., Pinggera W. F. Rapidly progressive glomerulonephritis treated with anticoagulants. Archives of International Medicine. 1972; 129: 17–85
- Rammer H. D. L. Reduction of renal edema by heparin in postichemic renal damage. Nephron. 1989; 51: 89–94
- Rosenman R. G., Solomon B., Byer S., Friedman M. Arresting effect of heparin upon experimental nephrosis in rats. Proceedings of the Society of Experimental Biological Medicine 1954; 86: 599–603
- Adachi T., Marklund S. L. Interactions between human extracellular superoxide dismutase C and sulfated polysaccharides. Journal of Biological Chemistry. 1989; 264: 8537–8541
- Blcch D. M., Border D. M., Jr. Hydroxide anion, HO−2, is an affinity reagent for the inactivation of yeast Cu, Zn-superoxide disrnutase: Modification of one histidine per subunit. Archives of Biochemistry and Biophysics. 1983; 224: 579–586
- Baycr W. F., Jr., Fridovich I., Mullenbach G. T., Hallewell R. Examination of the role of arginine-143 in the human copper and zinc superoxide disrnutase by specific mutagenesis. Journal of Biological Chemistry. 1987; 262: 11182–11187
- Monge J. C., Recondo E. F., Fernandez de Recondo M. E. Heparin and concanavalin A interaction as a model for studying the mechanism of the anticoagulant activity. Thrombosis Research 1989; 54: 237–243
- Jordan R. E., Nelson R. M., Kilpatrick I., Newgren J. O., Esmon P. C., Fournel M. A. lnactivation of human antithrombin by ncutrophil elastase. Journal of Biological Chemistry. 1989; 264: 10493–10500
- Folkman J., Weisz P. B., Joullie M. M., Li W. W., Ewing W. R. Control of angiogenesis with synthetic heparin. Science 1989; 243: 1490–1493
- Damon D. H., Lobb R. R., d'Amore P. C., Wagner J. A. Heparin potentiate the action of acidic fibroblast growth factor by prolonging its biological half-life. Journal of Cellular Physiology 1989; 138: 221–226
- Robinson-White A., Baylin S. B., Olivecrona T., Bcaven M. A. Binding of diamine oxidasc activity to rat and guinea pig microvascular endothclial cells. Journal of Clinical Investigation. 1985; 76: 93–100